Regarding the chemical class TRIM46 Inhibitors, this class is characterized by a diverse range of compounds primarily targeting signaling pathways and cellular processes that are indirectly related to the function of TRIM46. The inhibitors listed are mainly small molecule compounds that target key enzymes in various signaling cascades such as PI3K, MEK, MAPK, mTOR, and AKT. These pathways are crucial in regulating cellular processes like growth, proliferation, and stress response, which are areas where TRIM46 might play a role. The inhibitors operate by modulating these pathways, thereby exerting an influence on the cellular environment that affects the activity or expression of TRIM46. For instance, PI3K and AKT inhibitors like LY 294002 and Wortmannin disrupt the PI3K-AKT signaling axis, a pathway that could be involved in processes where TRIM46 has a role. Similarly, inhibitors targeting the MAPK pathway, such as PD 98059 and U0126, might indirectly influence TRIM46 activity by altering the cellular response to extracellular signals that govern cell division, differentiation, and survival.
Each of these compounds has unique characteristics in terms of their selectivity and potency against their primary targets. Their effects on TRIM46, however, are consequential to their primary mode of action, which is to disrupt specific signaling pathways. It is through this disruption that they may exert an indirect influence on TRIM46. This approach of targeting related pathways offers a strategic method to modulate the activity of proteins like TRIM46, especially in the absence of direct inhibitors. The compounds listed represent a range of chemical structures and properties, reflecting the diversity of mechanisms through which they can interact with cellular signaling pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that may alter AKT signaling, potentially influencing proteins like TRIM46. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor, could disrupt ERK/MAPK signaling, indirectly affecting TRIM46 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, might modulate stress-related pathways impacting TRIM46. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor, could alter cellular stress responses, potentially affecting TRIM46. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, may indirectly influence TRIM46 via AKT pathway modulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, could affect cellular growth pathways that interact with TRIM46. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
An inhibitor of MEK1/2, potentially influencing ERK/MAPK pathways linked to TRIM46. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor, might affect cytoskeletal dynamics, indirectly influencing TRIM46. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
AKT inhibitor, could modulate signaling pathways involving TRIM46. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $160.00 $345.00 | 12 | |
mTOR inhibitor, might indirectly affect TRIM46 through cellular growth control pathways. |